Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells-Reference-Cited by-同舟云学术

Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells

Published:2018-07-26 Issue:8 Volume:9 Page:
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Sulaiman Andrew,McGarry Sarah,Lam Ka Mien,El-Sahli Sara,Chambers Jason,Kaczmarek Shelby,Li Li,Addison Christina,Dimitroulakos Jim,Arnaout Angel,Nessim Carolyn,Yao Zemin,Ji Guang,Song Haiyan,Liu Sheng,Xie Ying,Gadde Suresh,Li Xuguang,Wang Lisheng

Funder

Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (Conseil de Recherches en Sciences Naturelles et en Génie du Canada)

Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada)

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/s41419-018-0811-7.pdf

Reference67 articles.

1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J. Clin. 66, 7–30 (2016).

2. Rakha, E. A., Reis-Filho, J. S. & Ellis, I. O. Basal-like breast cancer: a critical review. J. Clin. Oncol. 26, 2568–2581 (2008).

3. Dent, R. et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 13, 4429–4434 (2007).

4. Liedtke, C. et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J. Clin. Oncol. 26, 1275–1281 (2008).